V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250001901 | 250005755 | 1.67 | 138 | null | null | 2018-12-13 | null | null | null | CARBOPLATIN + GEMCITABINE | 101171290 |
| 250001903 | 250005757 | 1.6 | null | Palliative (P) | 2020-08-20 | 2020-09-09 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 101843309 |
| 250001914 | 250005765 | 0 | 84.7 | null | null | 2020-11-09 | NIVOLUMAB | null | null | NIVOLUMAB | 100996612 |
| 250001931 | 250005769 | 1.62 | null | null | null | 2020-01-21 | null | null | null | PEMBROLIZUMAB | 100300686 |
| 250001938 | 250005773 | 1.82 | 41.7 | Palliative (P) | 2020-03-28 | 2020-04-12 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101398065 |
| 250001939 | 250005774 | 1.64 | null | Palliative (P) | 2017-10-20 | 2017-12-02 | null | 02 | N | CARBOPLATIN + GEMCITABINE | 101605629 |
| 250001942 | 250005775 | 1.7 | 67.5 | null | null | 2014-10-27 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 100340193 |
| 250001949 | 250005778 | 1.71 | 81.6 | null | null | 2019-02-02 | CARBOPLATIN + GEMCITABINE | null | null | CARBOPLATIN + GEMCITABINE | 100615060 |
| 250001954 | 250005781 | 1.78 | 66 | null | null | 2020-01-22 | null | 02 | N | IPILIMUMAB + NIVOLUMAB | 101216449 |
| 250001958 | 250005782 | 1.54 | 0 | 03 | 2018-09-09 | 2018-10-29 | null | null | N | BLEOMYCIN + DACARBAZINE + DOXORUBICIN + VINBLASTINE | 101530452 |
| 250001962 | 250005785 | 1.8 | 9.1 | Palliative (P) | 2020-09-13 | 2020-10-25 | CARBOPLATIN | 02 | N | CARBOPLATIN + PEMETREXED | 101532937 |
| 250001963 | 250005786 | 1.74 | 45.4 | Curative (C) | 2017-11-17 | 2018-07-02 | Cyclophosphamide + Topotecan | N | null | VAI | 100528820 |
| 250001965 | 250005787 | 1.6 | 79 | null | null | 2019-09-28 | null | null | null | CAPECITABINE | 101502650 |
| 250001968 | 250005789 | 1.62 | 61.6 | 03 | null | 2019-04-17 | Tivozanib | Y | N | BACILLUS CALMETTE-GUERIN | 101545467 |
| 250001972 | 250005792 | 1.76 | 64.45 | Adjuvant (A) | 2019-08-08 | 2019-08-08 | Carboplatin + Liposomal Doxorubicin | 02 | N | ENZALUTAMIDE | 101798893 |
| 250001979 | 250005797 | 1.53 | 53.5 | null | 2018-06-28 | 2018-08-29 | null | 02 | N | STS RHABDOMYOSARCOMA RMS 2005 IVA | 101693136 |
| 250001983 | 250005799 | 1.62 | 84.4 | Curative (C) | 2019-07-02 | 2019-07-02 | Etoposide + Ifosfamide (3 days) | 01 | null | CARBOPLATIN + PACLITAXEL | 100060929 |
| 250001987 | 250005802 | 1.78 | 52 | null | 2019-03-03 | 2019-03-10 | null | 02 | N | TIVOZANIB | 101453197 |
| 250001989 | 250005804 | null | null | Palliative (P) | 2019-08-21 | 2019-08-21 | Atezolizumab | 02 | N | CARBOPLATIN | 100066854 |
| 250001991 | 250005805 | 1.6 | 59.3 | null | 2020-02-14 | 2020-02-14 | Carboplatin + Vinorelbine IV | N | null | CABOZANTINIB | 100150107 |
| 250001992 | 250005806 | 1.72 | 79.2 | null | 2020-03-08 | 2020-03-12 | null | N | null | CAPECITABINE + IRINOTECAN | 100629719 |
| 250001997 | 250005809 | 1.64 | 71.7 | null | 2018-08-13 | 2018-12-15 | null | 02 | N | CARBOPLATIN + PEMETREXED | 100847373 |
| 250002002 | 250005812 | 1.68 | 38.3 | null | 2020-06-06 | 2020-06-09 | null | 02 | null | CARBOPLATIN + FLUOROURACIL | 100263592 |
| 250002003 | 250005813 | null | null | null | 2018-07-07 | 2018-07-09 | BEP 5 Day | 02 | y | DOXORUBICIN | 100155505 |
| 250002004 | 250005814 | null | 10.7 | null | 2020-01-06 | 2020-01-10 | NB HRNBL-1 Isotretinoin | 02 | null | DOXORUBICIN + OLARATUMAB | 100990832 |
| 250002008 | 250005817 | null | null | null | null | 2016-12-29 | null | null | null | TRIAL UNSPECIFIED | 101282270 |
| 250002009 | 250005818 | 0 | 59.3 | null | 2021-05-16 | 2021-06-03 | Doxorubin 50mg/m2 | N | N | DOCETAXEL | 100776673 |
| 250002014 | 250005821 | 1.8 | 73.7 | null | 2019-01-23 | 2019-05-16 | null | 02 | null | CETUXIMAB | 100115437 |
| 250002019 | 250005822 | 1.21 | 16.3 | Adjuvant (A) | 2020-08-19 | 2020-09-14 | CETUXIMAB | 02 | N | ENZALUTAMIDE | 100506955 |
| 250002028 | 250005828 | 1.7 | 132 | Palliative (P) | 2017-01-13 | 2017-02-17 | SPIRE Trial | 02 | N | DOXORUBICIN + OLARATUMAB | 101207935 |
| 250002036 | 250005829 | 1.74 | 61.4 | null | 2018-04-30 | 2018-05-02 | null | 02 | N | CISPLATIN + FLUOROURACIL | 101318145 |
| 250002037 | 250005830 | null | null | Palliative (P) | null | 2019-07-20 | null | null | N | IPILIMUMAB + NIVOLUMAB | 100482337 |
| 250002038 | 250005831 | 1.33 | 88.5 | Palliative (P) | null | 2018-04-18 | Cisplatin + Pemetrexed | null | N | ATEZOLIZUMAB | 100690602 |
| 250002045 | 250005835 | 1.74 | 94.6 | Palliative (P) | 2017-03-08 | 2017-03-09 | Olaparib | 01 | N | IMATINIB | 100703044 |
| 250002052 | 250005840 | 1.65 | 71.2 | null | null | 2021-01-01 | null | 02 | N | DOXORUBICIN + IFOSFAMIDE | 100959026 |
| 250002053 | 250005841 | 0 | 49.6 | null | null | 2019-04-23 | MIFAMURTIDE | 02 | N | NB HRNBL-1 COJEC IND COURSE C | 100350391 |
| 250002059 | 250005847 | null | null | null | null | 2020-02-17 | Carboplatin + Liposomal Doxorubicin | null | null | CARBOPLATIN + RT | 100232944 |
| 250002060 | 250005848 | 1.78 | 40 | Palliative (P) | 2019-01-28 | 2019-02-08 | Atezolizumab | 02 | null | ATEZOLIZUMAB | 101603681 |
| 250002061 | 250005849 | null | null | null | null | 2019-12-21 | null | null | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100867497 |
| 250002062 | 250005850 | 0 | 86.4 | 03 | 2011-11-15 | 2012-08-11 | CARBOPLATIN | 02 | N | OLARATUMAB | 100922567 |
| 250002065 | 250005851 | 1.85 | 85.85 | Palliative (P) | 2018-01-30 | 2018-02-18 | null | 02 | N | PACLITAXEL | 101136275 |
| 250002069 | 250005853 | null | null | Curative (C) | null | 2019-08-01 | null | null | null | WT GUIDELINES CYCLOPHOS/DOXORUBICIN | 100019413 |
| 250002071 | 250005854 | 1.77 | 87 | Palliative (P) | 2019-10-21 | 2019-11-23 | null | 02 | N | DOXORUBICIN | 101152089 |
| 250002073 | 250005855 | 1.59 | 95.95 | Palliative (P) | null | 2019-08-12 | VIDE | 02 | N | DABRAFENIB + TRAMETINIB | 101020099 |
| 250002078 | 250005858 | 1.78 | 0 | 03 | 2020-11-11 | 2020-11-15 | null | 02 | null | CARBOPLATIN + FLUOROURACIL | 100686510 |
| 250002081 | 250005859 | null | null | Curative (C) | 2019-02-05 | 2019-03-27 | null | 02 | N | IMATINIB | 101847557 |
| 250002082 | 250005860 | null | null | null | null | 2020-06-23 | null | null | N | DOCETAXEL | 101377845 |
| 250002090 | 250005865 | 1.76 | 68 | Palliative (P) | 2016-06-22 | 2016-06-22 | null | 02 | N | NB HRNBL-1 COJEC IND COURSE C | 101042099 |
| 250002092 | 250005867 | 1.62 | 21.4 | Curative (C) | null | 2020-03-08 | CARBOPLATIN + ETOPOSIDE | null | N | IPILIMUMAB + NIVOLUMAB | 101264613 |
| 250002100 | 250005871 | 1.6 | 48.5 | Palliative (P) | 2017-06-08 | 2017-08-06 | Cisplatin + Radiotherapy | 02 | N | CYCLOPHOSPHAMIDE + VINORELBINE | 100020446 |